![](/images/Email.png)
TargetFibroblast growth factor receptor 1(Homo sapiens (Human))
EISAI R&D MANAGEMENT CO., LTD.
US Patent
EISAI R&D MANAGEMENT CO., LTD.
US Patent
Affinity DataIC50: 1.00E+4nMpH: 7.5 T: 2°CAssay Description:Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiad...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 1(Homo sapiens (Human))
EISAI R&D MANAGEMENT CO., LTD.
US Patent
EISAI R&D MANAGEMENT CO., LTD.
US Patent
Affinity DataIC50: 1.00E+4nMAssay Description:Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen™) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ I...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 1(Homo sapiens (Human))
EISAI R&D MANAGEMENT CO., LTD.
US Patent
EISAI R&D MANAGEMENT CO., LTD.
US Patent
Affinity DataIC50: 1.00E+4nMAssay Description:Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 μ...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 1(Homo sapiens (Human))
EISAI R&D MANAGEMENT CO., LTD.
US Patent
EISAI R&D MANAGEMENT CO., LTD.
US Patent
Affinity DataIC50: 1.00E+4nMAssay Description:Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (...More data for this Ligand-Target Pair
![](/img/powered_by_small.gif)